(Q67594854)
Statements
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome (English)
F. M. Foss
D. C. Ihde
D. L. Breneman
R. M. Phelps
A. B. Fischmann
G. P. Schechter
I. Linnoila
J. C. Breneman
J. D. Cotelingam
1 December 1992